PURPOSE: Tests for ocular Chlamydia trachomatis have not been well characterized, because there is no gold standard test. Latent class analysis (LCA) was performed to estimate the sensitivity and specificity of laboratory and clinical tests for trachoma in the absence of a gold standard. METHODS: Individual data from pretreatment, hyperendemic areas in Ethiopia were used. A clustered LCA was performed for three diagnostic tests: PCR and WHO simplified criteria grades of follicular trachoma (TF) and intense trachomatous inflammation (TI). RESULTS: Data from 2111 subjects in 40 villages were available. TF was estimated to be 87.3% (95% CI, 83.3-90.1) sensitive and 36.6% (95% CI, 23.6-40.3) specific; TI was estimated to be 53.6% (95% CI, 46.1-88.0) sensitive and 88.3% (95% CI, 83.3-92.0) specific, and PCR was estimated to be 87.5% (95% CI, 79.9-97.2) sensitive and 100% (95% CI 69.3-100) specific. CONCLUSIONS:LCA allows for an estimate of test characteristics without prior assumption of their performance. TF and TI were found to act in a complementary manner: TF is a sensitive test and TI is a specific test. PCR is highly specific but lacks sensitivity. The performance of these tests may be due to the time course of ocular chlamydial infection, and for this reason, results may differ in areas of low prevalence or recent mass treatment (ClinicalTrials.gov number, NCT00221364).
RCT Entities:
PURPOSE: Tests for ocular Chlamydia trachomatis have not been well characterized, because there is no gold standard test. Latent class analysis (LCA) was performed to estimate the sensitivity and specificity of laboratory and clinical tests for trachoma in the absence of a gold standard. METHODS: Individual data from pretreatment, hyperendemic areas in Ethiopia were used. A clustered LCA was performed for three diagnostic tests: PCR and WHO simplified criteria grades of follicular trachoma (TF) and intense trachomatous inflammation (TI). RESULTS: Data from 2111 subjects in 40 villages were available. TF was estimated to be 87.3% (95% CI, 83.3-90.1) sensitive and 36.6% (95% CI, 23.6-40.3) specific; TI was estimated to be 53.6% (95% CI, 46.1-88.0) sensitive and 88.3% (95% CI, 83.3-92.0) specific, and PCR was estimated to be 87.5% (95% CI, 79.9-97.2) sensitive and 100% (95% CI 69.3-100) specific. CONCLUSIONS: LCA allows for an estimate of test characteristics without prior assumption of their performance. TF and TI were found to act in a complementary manner: TF is a sensitive test and TI is a specific test. PCR is highly specific but lacks sensitivity. The performance of these tests may be due to the time course of ocular chlamydial infection, and for this reason, results may differ in areas of low prevalence or recent mass treatment (ClinicalTrials.gov number, NCT00221364).
Authors: A Bianchi; C Scieux; N Brunat; D Vexiau; M Kermanach; P Pezin; M Janier; P Morel; P H Lagrange Journal: Sex Transm Dis Date: 1994 Jul-Aug Impact factor: 2.830
Authors: Jon L Yang; Kevin C Hong; Julius Schachter; Jeanne Moncada; Takele Lekew; Jenafir I House; Zhaoxia Zhou; Melissa D Neuwelt; Tina Rutar; Colleen Halfpenny; Neelima Shah; John P Whitcher; Thomas M Lietman Journal: Invest Ophthalmol Vis Sci Date: 2008-08-08 Impact factor: 4.799
Authors: H R Taylor; S L Johnson; R A Prendergast; J Schachter; C R Dawson; A M Silverstein Journal: Invest Ophthalmol Vis Sci Date: 1982-10 Impact factor: 4.799
Authors: Jocelyn Thein; Puning Zhao; Hansheng Liu; Jingjing Xu; Hem Jha; Yinghui Miao; Louis Pizzarello; Lisa Tapert; Julius Schachter; Michèle Mabon; Susan Osaki-Holm; Thomas Lietman; Anne Paxton Journal: Ophthalmic Epidemiol Date: 2002-10 Impact factor: 1.648
Authors: S C Shiboski; C H Shiboski; L A Criswell; A N Baer; S Challacombe; H Lanfranchi; M Schiødt; H Umehara; F Vivino; Y Zhao; Y Dong; D Greenspan; A M Heidenreich; P Helin; B Kirkham; K Kitagawa; G Larkin; M Li; T Lietman; J Lindegaard; N McNamara; K Sack; P Shirlaw; S Sugai; C Vollenweider; J Whitcher; A Wu; S Zhang; W Zhang; J S Greenspan; T E Daniels Journal: Arthritis Care Res (Hoboken) Date: 2012-04 Impact factor: 4.794
Authors: Laura Dize; Sheila West; James A Williams; Barbara Van Der Pol; Thomas C Quinn; Charlotte A Gaydos Journal: J Clin Microbiol Date: 2013-03-13 Impact factor: 5.948
Authors: Bruce D Gaynor; Abdou Amza; Sintayehu Gebresailassie; Boubacar Kadri; Baido Nassirou; Nicole E Stoller; Sun N Yu; Puja A Cuddapah; Jeremy D Keenan; Thomas M Lietman Journal: Am J Trop Med Hyg Date: 2014-07-07 Impact factor: 2.345
Authors: Jeremy D Keenan; Craig W See; Jeanne Moncada; Berhan Ayele; Teshome Gebre; Nicole E Stoller; Charles E McCulloch; Travis C Porco; Bruce D Gaynor; Paul M Emerson; Julius Schachter; Thomas M Lietman Journal: Invest Ophthalmol Vis Sci Date: 2012-01-25 Impact factor: 4.799
Authors: Artemis Koukounari; Irini Moustaki; Nicholas C Grassly; Isobel M Blake; María-Gloria Basáñez; Manoj Gambhir; David C W Mabey; Robin L Bailey; Matthew J Burton; Anthony W Solomon; Christl A Donnelly Journal: Am J Epidemiol Date: 2013-04-01 Impact factor: 4.897
Authors: E Brook Goodhew; Jeffrey W Priest; Delynn M Moss; Guangming Zhong; Beatriz Munoz; Harran Mkocha; Diana L Martin; Sheila K West; Charlotte Gaydos; Patrick J Lammie Journal: PLoS Negl Trop Dis Date: 2012-11-01